Wells Fargo & Company Precigen, Inc. Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Precigen, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 104,544 shares of PGEN stock, worth $98,271. This represents 0.0% of its overall portfolio holdings.

Number of Shares

104,544

Previous 97,231 7.52%

Holding current value

$98,271

Previous $140,000 17.86%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$1.27 - $1.75 $9,287 - $12,797	7,313 Added 7.52%	104,544 $165,000
Q1 2024 May 10, 2024	SELL	$1.21 - $1.75 $1,643 - $2,376	-1,358 Reduced 1.38%	97,231 $140,000
Q4 2023 Feb 09, 2024	BUY	$0.89 - $1.41 $7,142 - $11,315	8,025 Added 8.86%	98,589 $132,000
Q3 2023 Nov 13, 2023	SELL	$1.08 - $1.85 $15,528 - $26,599	-14,378 Reduced 13.7%	90,564 $128,000
Q2 2023 Aug 15, 2023	BUY	$0.96 - $1.4 $29,449 - $42,947	30,677 Added 41.31%	104,942 $120,000
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $10,936 - $27,217	12,428 Added 20.1%	74,265 $78,000
Q4 2022 Feb 13, 2023	SELL	$1.27 - $2.26 $111,085 - $197,679	-87,469 Reduced 58.58%	61,837 $93,000
Q3 2022 Nov 14, 2022	SELL	$1.41 - $2.79 $545 - $1,079	-387 Reduced 0.26%	149,306 $317,000
Q2 2022 Aug 12, 2022	BUY	$1.15 - $2.53 $43,039 - $94,687	37,426 Added 33.34%	149,693 $200,000
Q1 2022 May 16, 2022	SELL	$1.91 - $3.98 $101,394 - $211,282	-53,086 Reduced 32.1%	112,267 $237,000
Q4 2021 Feb 14, 2022	SELL	$3.53 - $5.5 $1.12 Million - $1.74 Million	-316,424 Reduced 65.68%	165,353 $613,000
Q3 2021 Nov 15, 2021	BUY	$4.99 - $6.55 $449,848 - $590,482	90,150 Added 23.02%	481,777 $2.4 Million
Q2 2021 Aug 16, 2021	BUY	$6.24 - $8.22 $237,893 - $313,379	38,124 Added 10.78%	391,627 $2.55 Million
Q1 2021 May 13, 2021	BUY	$6.74 - $10.95 $785,688 - $1.28 Million	116,571 Added 49.2%	353,503 $2.44 Million
Q4 2020 Feb 09, 2021	BUY	$3.75 - $10.56 $47,036 - $132,454	12,543 Added 5.59%	236,932 $2.42 Million
Q3 2020 Nov 05, 2020	SELL	$3.5 - $6.2 $153,454 - $271,832	-43,844 Reduced 16.35%	224,389 $785,000
Q2 2020 Aug 13, 2020	BUY	$2.16 - $5.46 $233,899 - $591,247	108,287 Added 67.7%	268,233 $1.34 Million
Q1 2020 May 14, 2020	BUY	$1.46 - $7.19 $233,521 - $1.15 Million	159,946 New	159,946 $545,000

Others Institutions Holding PGEN

# of Institutions

143

Shares Held

144M

Call Options Held

292K

Put Options Held

53.8K

View Full List

About PRECIGEN, INC.

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $196M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

More about PGEN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Precigen, Inc. Transaction History